微电生理-U
(688351)
| 流通市值：26.73亿 | | | 总市值：100.76亿 |
| 流通股本：1.25亿 | | | 总股本：4.71亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 232,794,654.03 | 534,934,783.76 | 399,829,346.01 | 265,530,944.31 |
| 应收票据及应收账款 | 50,864,397 | 60,088,173.39 | 59,382,832.62 | 54,963,833.89 |
| 应收账款 | 50,864,397 | 60,088,173.39 | 59,382,832.62 | 54,963,833.89 |
| 预付款项 | 12,597,402.44 | 7,812,863.19 | 12,442,175.12 | 6,741,612.14 |
| 其他应收款合计 | 1,250,139.03 | 1,315,849.24 | 1,876,711.13 | 2,440,782.53 |
| 存货 | 130,592,317.76 | 125,428,958.08 | 132,285,864.94 | 122,388,071.17 |
| 其他流动资产 | - | - | - | 400,958.58 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,572,753,795.81 | 1,552,294,967.94 | 1,544,532,039.55 | 1,519,229,127.83 |
| 非流动资产: | | | | |
| 长期股权投资 | 70,574,156.42 | 70,919,561.61 | 71,198,242.18 | 71,545,027.55 |
| 固定资产 | 90,719,929.65 | 92,327,692.41 | 87,820,375.61 | 89,970,720.25 |
| 使用权资产 | 17,683,869.61 | 20,008,094.62 | 22,307,056.36 | 24,606,018.07 |
| 无形资产 | 76,869,152.43 | 80,176,571.02 | 82,530,712.67 | 85,876,259.86 |
| 开发支出 | 29,367,145.73 | 25,918,158.42 | 23,121,302.23 | 19,686,615.41 |
| 长期待摊费用 | 5,570,011.98 | 6,326,229.7 | 7,078,616.66 | 7,841,878.11 |
| 递延所得税资产 | 2,860,416.39 | 3,204,074.66 | 3,913,825.42 | 3,913,825.42 |
| 其他非流动资产 | 1,709,673.7 | 209,073.7 | 958,413.6 | 598,913.6 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 295,354,355.91 | 299,089,456.14 | 298,928,544.73 | 304,039,258.27 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,868,108,151.72 | 1,851,384,424.08 | 1,843,460,584.28 | 1,823,268,386.1 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 54,380,065.73 | 56,755,798.9 | 59,494,232.23 | 37,371,198.11 |
| 应付账款 | 54,380,065.73 | 56,755,798.9 | 59,494,232.23 | 37,371,198.11 |
| 合同负债 | 3,763,262.19 | 3,871,890.02 | 3,426,966.07 | 3,398,021.32 |
| 应付职工薪酬 | 17,214,395.72 | 18,269,832.99 | 19,729,711.49 | 23,634,010.03 |
| 应交税费 | 3,235,462.16 | 4,488,444.55 | 3,435,605.25 | 2,475,426.98 |
| 其他应付款合计 | 16,388,607.3 | 17,248,281.18 | 18,202,374.02 | 20,080,704.81 |
| 一年内到期的非流动负债 | 9,002,870.91 | 8,265,641.42 | 9,364,151.99 | 9,139,384.05 |
| 其他流动负债 | 404,741.29 | 357,992.34 | 359,154.11 | 336,724.66 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 104,389,405.3 | 109,257,881.4 | 114,012,195.16 | 96,435,469.96 |
| 非流动负债: | | | | |
| 租赁负债 | 10,066,571.7 | 13,094,856.33 | 14,686,398.05 | 16,952,785.4 |
| 预计负债 | 8,095,737.83 | 7,842,582.86 | 7,354,530.53 | 6,965,750.9 |
| 递延收益 | 12,180,480.87 | 13,377,350.08 | 12,849,240.69 | 14,165,434.19 |
| 递延所得税负债 | 2,652,580.44 | 3,001,214.19 | 3,690,902.71 | 3,690,902.71 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 32,995,370.84 | 37,316,003.46 | 38,581,071.98 | 41,774,873.2 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 137,384,776.14 | 146,573,884.86 | 152,593,267.14 | 138,210,343.16 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 470,600,000 | 470,600,000 | 470,600,000 | 470,600,000 |
| 资本公积 | 1,267,672,893.65 | 1,266,474,562.13 | 1,265,374,824.98 | 1,263,734,736.53 |
| 其他综合收益 | 522.72 | - | - | - |
| 未分配利润 | -7,550,040.79 | -32,264,022.91 | -45,107,507.84 | -49,276,693.59 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,730,723,375.58 | 1,704,810,539.22 | 1,690,867,317.14 | 1,685,058,042.94 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,730,723,375.58 | 1,704,810,539.22 | 1,690,867,317.14 | 1,685,058,042.94 |
| 负债和股东权益合计 | 1,868,108,151.72 | 1,851,384,424.08 | 1,843,460,584.28 | 1,823,268,386.1 |
| 公告日期 | 2024-10-22 | 2024-08-22 | 2024-04-26 | 2024-03-30 |
| 审计意见(境内) | | | | 标准无保留意见 |